Cargando…
Impact of metabolic syndrome and metabolic dysfunction-associated fatty liver disease on cardiovascular risk by the presence or absence of type 2 diabetes and according to sex
BACKGROUND: To determine the impact of metabolic syndrome (MetS) and/or metabolic dysfunction-associated fatty liver disease (MAFLD), which are pathophysiologically similar and include insulin resistance, on the development of new-onset cardiovascular disease with and without type 2 diabetes and acc...
Autores principales: | Matsubayashi, Yasuhiro, Fujihara, Kazuya, Yamada-Harada, Mayuko, Mitsuma, Yurie, Sato, Takaaki, Yaguchi, Yuta, Osawa, Taeko, Yamamoto, Masahiko, Kitazawa, Masaru, Yamada, Takaho, Kodama, Satoru, Sone, Hirohito |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9161475/ https://www.ncbi.nlm.nih.gov/pubmed/35655263 http://dx.doi.org/10.1186/s12933-022-01518-4 |
Ejemplares similares
-
Rates and risk factors for amputation in people with diabetes in Japan: a historical cohort study using a nationwide claims database
por: Kaneko, Masanori, et al.
Publicado: (2021) -
Impact of prior cerebrovascular disease and glucose status on incident cerebrovascular disease in Japanese
por: Oe, Momoko, et al.
Publicado: (2021) -
Ability of Current Machine Learning Algorithms to Predict and Detect Hypoglycemia in Patients With Diabetes Mellitus: Meta-analysis
por: Kodama, Satoru, et al.
Publicado: (2021) -
Combination of diabetes mellitus and lack of habitual physical activity is a risk factor for functional disability in Japanese
por: Fujihara, Kazuya, et al.
Publicado: (2020) -
Association of estimated plasma volume and weight loss after long‐term administration and subsequent discontinuation of the sodium‐glucose cotransporter‐2 inhibitor tofogliflozin
por: Matsubayashi, Yasuhiro, et al.
Publicado: (2021)